Gliclazide Sustained-release Tablet Market size is estimated to be USD 1.2 Billion in 2024 and is expected to reach USD 1.8 Billion by 2033 at a CAGR of 5% from 2026 to 2033.
The Malaysia Gliclazide Sustained-release Tablet Market has seen significant growth over recent years, driven by increasing demand from the pharmaceutical industry and the rising incidence of Type 2 diabetes across the nation. Gliclazide, a medication primarily used to manage diabetes, has become a staple in treatment regimens due to its efficacy and relatively fewer side effects. The sustained-release formulation ensures a controlled release of the active ingredient over a prolonged period, offering patients better blood sugar control and a more convenient dosing schedule.
One of the key drivers of the market for Gliclazide Sustained-release Tablets is the rising prevalence of diabetes in Malaysia. As per reports, Malaysia has one of the highest rates of diabetes in Southeast Asia, with millions of individuals affected by this chronic condition. This has created a growing demand for effective treatments, and Gliclazide, particularly in its sustained-release form, has garnered significant attention for its therapeutic benefits. The sustained-release version of Gliclazide provides a more consistent and controlled release of the drug, reducing the risk of hypoglycemic episodes while maintaining optimal glucose levels throughout the day.
The pharmaceutical industry has also responded to the increasing demand for such medications by ramping up production of Gliclazide Sustained-release Tablets. Local manufacturers are scaling up production capabilities to meet market needs, while international pharmaceutical companies are also investing in the Malaysian market due to its large consumer base. As more companies enter the market, competition is intensifying, driving innovation and ensuring competitive pricing, which benefits consumers and healthcare providers alike.
Industries within the healthcare sector, particularly hospitals, clinics, and pharmacies, have recognized the importance of providing affordable and reliable diabetic medications. As the demand for Gliclazide Sustained-release Tablets grows, suppliers and healthcare providers are focusing on meeting the specific needs of patients, such as ensuring consistent drug quality and availability. Furthermore, the growing awareness among healthcare professionals about the importance of sustained-release formulations for managing long-term conditions like diabetes is driving their preference for this form of Gliclazide over other immediate-release alternatives.
Additionally, healthcare policies and government support play a crucial role in shaping the market dynamics. Malaysia’s government has made significant strides in addressing the diabetes epidemic, implementing public health initiatives, and supporting the availability of essential medications, including Gliclazide Sustained-release Tablets. This has contributed to both an increase in treatment access and a steady rise in market demand.
As the Malaysia Gliclazide Sustained-release Tablet Market continues to evolve, ongoing innovations in drug delivery systems and formulation technologies are expected to further boost market growth. The combination of rising diabetes prevalence, increasing healthcare awareness, and advancements in pharmaceutical manufacturing techniques will ensure that this vital medication remains a cornerstone of diabetes treatment in Malaysia.
Get an In-Depth Research Analysis of the Malaysia Gliclazide Sustained-release Tablet Market Size And Forecast [2025-2032]
Â
Servier Laboratories
Torrent Pharmaceuticals
Aurobindo Pharma
Teva
Zydus Cadila Healthcare
Sanofi S.A.
Mylan Pharmaceuticals
Accord Healthcare
Lukang Jituan Saite Yaoye
Shijiazhuang SIYAO
Yiling Pharmaceutical
Â
By 2030, Malaysia is expected to witness significant momentum in the market research industry, aligning with the global projection of surpassing $120 billion, driven by a compound annual growth rate (CAGR) of over 5.8% from 2023 to 2030. The industry in Malaysia is being reshaped by technological disruptions, particularly through the adoption of machine learning, artificial intelligence, and advanced data analytics. These technologies provide businesses with predictive analysis and real-time consumer insights, enabling smarter and more precise decision-making. As part of the broader Asia-Pacific region, Malaysia is positioned to contribute substantially to the over 35% revenue growth expected from this region. Additionally, the adoption of innovative techniques such as mobile surveys, social listening, and online panels is rapidly gaining ground in Malaysia, emphasizing speed, precision, and customization, and driving a new era of data-driven strategies across industries.
Â
Get Discount On The Purchase of the Malaysia Gliclazide Sustained-release Tablet Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Malaysia Gliclazide Sustained-release Tablet Market
Type 2 Diabetes Mellitus
Gestational Diabetes
Other Endocrine Disorders
12 mg Tablets
30 mg Tablets
Other Dosage Variants
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Adults
Geriatric Patients
Pediatric Patients
Oral Administration
Combination Therapy with Other Antidiabetic Medications
Intravenous Administration (less common)
1. Singapore
Relationship: Strong economic ties; major trading partner.
Highlights: Advanced financial and logistics hub; shares deep cross-border business and travel links with Malaysia.
2. Indonesia
Relationship: Largest ASEAN economy; close cultural and linguistic ties.
Highlights: Major market for Malaysian exports; shared initiatives in palm oil, labor, and regional security.
3. Thailand
Relationship: Land-border neighbor with active cross-border trade.
Highlights: Strong tourism, agricultural, and automotive collaboration.
4. Brunei
Relationship: Close diplomatic and energy-sector ties.
Highlights: Joint ventures in oil & gas; similar Malay cultural heritage.
5. Philippines
Relationship: Regional partner in ASEAN; maritime neighbor.
Highlights: Collaborations in education, labor migration, and disaster relief.
6. Vietnam
Relationship: Growing trade and investment partner.
Highlights: Rising manufacturing hub; strong demand for Malaysian technology and services.
7. Cambodia, Laos, and Myanmar
Relationship: Developing ASEAN members with growing economic ties to Malaysia.
Highlights: Opportunities in construction, retail, and financial services.
For More Information or Query, Visit @ Malaysia Gliclazide Sustained-release Tablet Market Research Analysis
1. Introduction of the Malaysia Gliclazide Sustained-release Tablet Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Malaysia Gliclazide Sustained-release Tablet Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Malaysia Gliclazide Sustained-release Tablet Market, By Type
6. Malaysia Gliclazide Sustained-release Tablet Market, By Application
7. Malaysia Gliclazide Sustained-release Tablet Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia
Vietnam
8. Malaysia Gliclazide Sustained-release Tablet Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/